Glycoprotein platelet inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Glycoprotein platelet inhibitors prevent platelet adhesion by binding to the glycoprotein IIb/IIIa receptors on the plasma membrane of platelets. They stop the actual substrates of the glycoprotein receptors from binding to the receptor, so inhibit platelets from sticking together to form a thrombus, which can lead to stroke, myocardial infarction or deep vein thrombosis.
Glycoprotein platelet inhibitors are used in patients with angina, after a heart attack, angioplasty or other types of coronary vasculature procedures.
|Drug Name ( View by: Brand | Generic )||Reviews||Ratings|
|eptifibatide systemic (Pro, More...)
|abciximab systemic (Pro, More...)
|tirofiban systemic (Pro, More...)
Medical conditions associated with glycoprotein platelet inhibitors: